Stocks · Health care · Pharmaceutical Preparations

Viatris

VTRS Clue Score21
United States Fiscal year ends December CIK 0001792044 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Paul Campbell
23 Mar 2026
See Remarks
Sell
21,350
$13.28
$283.54K
Paul Campbell
11 Nov 2024
See Remarks
Sell
26,925
$12.88
$346.69K
Rajiv Malik
12 Sep 2024
Director
Sell
139,681
$11.66
$1.63M
Rajiv Malik
12 Sep 2024
Director
Sell indirect
60,319
$11.71
$706.55K
Rajiv Malik
30 Aug 2024
Director
Sell indirect
50,000
$12.00
$600.00K
Rajiv Malik
28 Aug 2024
Director
Sell indirect
50,000
$11.90
$595.08K
Rajiv Malik
23 Aug 2024
Director
Sell indirect
100,000
$11.75
$1.18M
Rajiv Malik
22 Aug 2024
Director
Sell indirect
100,000
$11.73
$1.17M
Rajiv Malik
21 Aug 2024
Director
Sell indirect
100,000
$11.75
$1.18M
Rajiv Malik
14 Jun 2024
Director
Sell
264,300
$10.18
$2.69M
Rajiv Malik
13 Jun 2024
Director
Sell
85,660
$10.52
$900.74K
Brian Roman
28 May 2024
Chief Legal Officer
Sell
89,419
$10.38
$928.43K
Anthony Mauro
13 Mar 2024
See Remarks
Sell
250,000
$12.09
$3.02M
Paul Campbell
5 Mar 2024
See Remarks
Sell
24,353
$12.33
$300.27K
Xiangyang (Sean) Ni
24 Nov 2023
President, Greater China
Sell
14,937
$9.37
$139.94K
Xiangyang (Sean) Ni
6 Mar 2023
President, Greater China
Sell
3,148
$11.08
$34.89K
Xiangyang (Sean) Ni
3 Mar 2023
President, Greater China
Sell
3,093
$11.18
$34.58K
Xiangyang (Sean) Ni
28 Feb 2023
President, Greater China
Sell
5,250
$11.22
$58.89K
Xiangyang (Sean) Ni
25 Nov 2022
President, Greater China
Sell
12,800
$10.95
$140.22K
der Meer Mohr Pauline van
17 Aug 2022
Director
Sell
9,440
$10.58
$99.91K
Menassie Taddese
27 May 2022
See Remarks
Sell
8,813
$12.07
$106.41K
Robert J Coury
11 Mar 2022
Executive Chairman
Sell indirect
250,000
$10.07
$2.52M
Robert J Coury
9 Mar 2022
Executive Chairman
Sell indirect
250,000
$10.28
$2.57M

What was left out

Form 4 filings counted 280
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 2
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 1,394,932,371
Sales filed before the plan box existed 8
History held since 16 Nov 2020